1. Home
  2. TUYA vs MGTX Comparison

TUYA vs MGTX Comparison

Compare TUYA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

SELL

Current Price

$1.67

Market Cap

1.0B

Sector

Technology

ML Signal

SELL

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.40

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
MGTX
Founded
2014
2015
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TUYA
MGTX
Price
$1.67
$9.40
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$3.17
★ $27.75
AVG Volume (30 Days)
655.3K
★ 1.0M
Earning Date
11-23-2026
11-12-2026
Dividend Yield
★ 6.78%
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 1.30
Revenue
N/A
★ $81,391,000.00
Revenue This Year
$12.58
$314.19
Revenue Next Year
$11.55
N/A
P/E Ratio
$27.45
★ $7.65
Revenue Growth
N/A
★ 144.57
52 Week Low
$1.60
$6.62
52 Week High
$2.61
$15.35

Technical Indicators

Market Signals
Indicator
TUYA
MGTX
Relative Strength Index (RSI) 42.80 23.75
Support Level $1.67 $8.84
Resistance Level $1.75 $10.06
Average True Range (ATR) 0.04 0.50
MACD 0.00 -0.09
Stochastic Oscillator 28.57 3.29

Price Performance

Historical Comparison
TUYA
MGTX

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: